USA TINUS PHARMA INC – Trademark Portfolio
Entity Type: 03
USA TINUS PHARMA INC holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 17 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 8 trademarks are registered and 4 are pending. Notable registered marks include ONISC, AIDEVI, FLONTY, WILAKON, and EASYTONE. The owner is based in CHINO, CA.
13661 BENSON AVE
CHINO, CA 91710
Showing of trademarks Trademarks
Trademark Classifications
USA TINUS PHARMA INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does USA TINUS PHARMA INC have?
USA TINUS PHARMA INC has 19 U.S. trademarks filed with the USPTO. Of these, 8 registered, 4 pending, 7 abandoned.
What trademark classes does USA TINUS PHARMA INC file in?
USA TINUS PHARMA INC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are USA TINUS PHARMA INC's most well-known trademarks?
USA TINUS PHARMA INC's registered trademark portfolio includes well-known marks such as ONISC, AIDEVI, FLONTY, WILAKON, and EASYTONE. These are among 8 currently registered trademarks in the portfolio.
What is USA TINUS PHARMA INC's trademark registration success rate?
USA TINUS PHARMA INC has a 53% trademark registration rate, with 8 out of 15 resolved applications resulting in successful registration. Currently, 4 applications are pending review.